TOMASETTI, CARMINE
 Distribuzione geografica
Continente #
NA - Nord America 863
AS - Asia 351
EU - Europa 340
AF - Africa 30
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.598
Nazione #
US - Stati Uniti d'America 843
SG - Singapore 171
IT - Italia 154
CN - Cina 130
IE - Irlanda 45
VN - Vietnam 42
CI - Costa d'Avorio 30
FI - Finlandia 29
DE - Germania 26
NL - Olanda 24
CA - Canada 20
SE - Svezia 19
GB - Regno Unito 18
BR - Brasile 9
FR - Francia 5
UA - Ucraina 5
RU - Federazione Russa 4
PK - Pakistan 3
BG - Bulgaria 2
CL - Cile 2
ES - Italia 2
EU - Europa 2
IN - India 2
PL - Polonia 2
RO - Romania 2
AR - Argentina 1
CH - Svizzera 1
IS - Islanda 1
JP - Giappone 1
PT - Portogallo 1
TR - Turchia 1
TW - Taiwan 1
Totale 1.598
Città #
Chandler 165
Singapore 140
Millbury 60
Ashburn 46
Beijing 45
Dong Ket 42
Princeton 41
Santa Clara 40
Nanjing 36
Des Moines 31
Napoli 28
Norwalk 22
Amsterdam 19
Ottawa 19
Wilmington 18
Seattle 15
Boston 12
Lawrence 11
Shenyang 10
Nanchang 9
Jacksonville 7
Jiaxing 7
Redwood City 7
Naples 6
Ortona 6
Woodbridge 6
Hebei 5
Nuremberg 5
Changsha 4
Gallipoli 4
Rome 4
Tamworth 4
Torino 4
Caivano 3
Catania 3
Dublin 3
Fremont 3
Milan 3
Münster 3
Portici 3
Rawalpindi 3
Salerno 3
Somma Vesuviana 3
Southend 3
Tianjin 3
Barakaldo 2
Falls Church 2
Hangzhou 2
Horia 2
Houston 2
Indiana 2
Kronberg 2
Martock 2
Mestre 2
New York 2
Niterói 2
Nola 2
Pozzuoli 2
Rio De Janeiro 2
Rowley 2
Shanghai 2
Sofia 2
Southwark 2
Wuhan 2
Altavilla Irpina 1
Ann Arbor 1
Atlanta 1
Avellino 1
Boardman 1
Borgo San Dalmazzo 1
Cambridge 1
Capoterra 1
Castellammare Di Stabia 1
Chieti 1
Concordia Sagittaria 1
Denver 1
Duncan 1
Durham 1
Edinburgh 1
Faenza 1
Fort Worth 1
Genova 1
Hanover 1
Kagoya 1
Kunming 1
Lanciano 1
Lappeenranta 1
Lisbon 1
Lissone 1
Olivos 1
Paris 1
Pellezzano 1
Pescara 1
Polska 1
Pune 1
Reykjavík 1
Sarno 1
Swindon 1
São Paulo 1
Taipei 1
Totale 988
Nome #
Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine 62
Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling 59
Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). 58
D-aspartate dysregulation in Ddo-/- mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum 58
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 45
Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance 45
Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor 41
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression 41
May second generation long-acting injectable antipsychotics be prescribed as a first-line treatment of first episode in patients with schizophrenia? An overview. 41
Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia 41
Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. 39
The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes 39
Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins 39
New advances in the treatment of generalized anxiety disorder: The multimodal antidepressant vortioxetine 38
The role of melatonin in mood disorders 38
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study 37
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in “real-world,” everyday clinical practice 36
Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions 36
MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective 35
Switching antipsychotics: Imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats 35
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones 35
Immediate-early genes modulation by antipsychotics: Translational implications for a putative gateway to drug-induced long-term brain changes 34
Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action 33
Eradicating suicide at its roots: Preclinical bases and clinical evidence of the efficacy of ketamine in the treatment of suicidal behaviors 33
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies beyond Dopamine Receptor Antagonism 32
Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches. 31
Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials 31
An Update on Glutamatergic System in Suicidal Depression and on the role of Esketamine 31
Alexithymia, resilience, somatic sensations and their relationships with suicide ideation in drug naïve patients with first-episode major depression: An exploratory study in the “real world” everyday clinical practice 31
The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions 30
The ‘dead man walking’ disorder: an update on Cotard’s syndrome 29
Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment 28
Sensation seeking in major depressive patients: relationship to sub-threshold bipolarity and cyclothymic temperament 28
“Resistenza alla gestione farmacologica della depressione bipolare resistente: Refrattarietà vs. tolleranza a litio in pazienti precedentemente responsivi. Inquadramento clinico, cenni neurobiologici, e prospettive terapeutiche.” – Evento: “Unveiling the dark side of the mood: nuove prospettive diagnostiche e terapeutiche per il trattamento dei disturbi depressivi”. Giulianova (Teramo), 6 Ottobre 2016. 27
Alexithymia, responsibility attitudes and suicide ideation among outpatients with obsessive-compulsive disorder: An exploratory study 26
When Clozapine Fails: Augmentation Strategies in the Management of Clozapine-Resistant Schizophrenia 26
A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder 25
Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine 25
Scaffolding Proteins of the Post-synaptic Density Contribute to Synaptic Plasticity by Regulating Receptor Localization and Distribution: Relevance for Neuropsychiatric Diseases 23
The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review 23
Alexithymia, suicide ideation, affective temperaments and homocysteine levels in drug naïve patients with post-traumatic stress disorder: an exploratory study in the everyday ‘real world’ clinical practice 23
An update of safety of clinically used atypical antipsychotics 22
Prevalence and clinical features associated to bipolar disorder-migraine comorbidity: A systematic review 22
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy 21
The role of intranasal oxytocin in the treatment of patients with schizophrenia: a systematic review 20
Suicide during perinatal period: Epidemiology, risk factors, and clinical correlates 19
Differential Adaptive Changes in Dopaminergic System by Acute vs. Subchronic Ketamine: Relevance for Psychosis Pathophysiology and Treatment 18
Earthquakes, economic crisis and, now, COVID-19: the cry of yell of Central Italy 18
A Postsynaptic Density Immediate Early Gene-Based Connectome Analysis of Acute NMDAR Blockade and Reversal Effect of Antipsychotic Administration 17
The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice 16
S-Adenosyl-L-Methionine for Major Depressive Disorder” in the book entitled:” Melatonin, Neuroprotective Agents and Antidepressant Therapy 15
Modulation of glutamatergic functional connectivity by a prototypical antipsychotic: Translational inference from a postsynaptic density immediate-early gene-based network analysis 13
Novel pathways in the treatment of major depression: Focus on the glutamatergic system 13
Understanding the Complex of Suicide in Depression: from Research to Clinics 11
The Homer1 family of proteins at the crossroad of dopamine-glutamate signaling: An emerging molecular “Lego” in the pathophysiology of psychiatric disorders. A systematic review and translational insight 9
The Problem of Eating Disorders and Comorbid Psychostimulants Abuse - A Mini Review 8
Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment 7
Second Generation Long-Acting Antipsychotics in the Treatment of Bipolar Disorder: A Clinical Viewpoint 4
Totale 1.720
Categoria #
all - tutte 8.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.140


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202076 0 0 0 0 1 0 0 0 0 50 19 6
2020/2021123 13 7 8 3 3 18 6 3 10 1 7 44
2021/2022305 12 1 1 3 0 22 1 9 51 39 53 113
2022/2023370 54 21 24 9 59 49 3 36 61 23 17 14
2023/2024242 16 49 15 14 11 17 15 42 0 3 39 21
2024/2025211 63 132 2 5 9 0 0 0 0 0 0 0
Totale 1.720